INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

RENAISSANCE TECHNOLOGIES LLC's Holding History (CIK: 0001037389)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 825,800 Value ($000) $15 Avg Close Range
Q2 2023
Shares 879,400 Value ($000) $10 Avg Close Range
Q1 2023
Shares 1,050,200 Value ($000) $14 Avg Close Range
Q4 2022
Shares 708,300 Value ($000) $9 Avg Close Range
Q3 2022
Shares 739,200 Value ($000) $10,312 Avg Close Range
Q2 2022
Shares 393,400 Value ($000) $5,433 Avg Close Range
Q1 2022
Shares 215,200 Value ($000) $3,501 Avg Close Range
Q4 2021
Shares 243,569 Value ($000) $3,968 Avg Close Range
Q3 2021
Shares 199,600 Value ($000) $2,964 Avg Close Range
Q1 2021
Shares 35,600 Value ($000) $822 Avg Close Range
Q4 2020
Shares 437,000 Value ($000) $10,794 Avg Close Range
Q3 2020
Shares 244,700 Value ($000) $10,145 Avg Close Range
Q2 2020
Shares 320,200 Value ($000) $15,341 Avg Close Range
Q1 2020
Shares 306,400 Value ($000) $19,291 Avg Close Range
Q4 2019
Shares 92,200 Value ($000) $11,425 Avg Close Range
Q2 2017
Shares 5,100 Value ($000) $617 Avg Close Range
Q3 2015
Shares 61,600 Value ($000) $10,217 Avg Close Range
Q2 2015
Shares 61,400 Value ($000) $14,821 Avg Close Range
Q1 2014
Shares 6,500 Value ($000) $2,144 Avg Close Range